Once daily Tedizolid effective for Acute Skin Infections


Once daily Tedizolid has a similar adverse effect profile  as that of twice daily linezolid in treating acute bacterial skin infections and skin structure infections. This was found out after a phase 3 study called the TR-701 FA vs Linezolid for the treatment of acute bacterial skin and skin structure infections, published online June 6 in Lancet Infectious Disease. 4

Tedizolid could become a useful option for treating  acute bacterial skin infection and skin structure infections. 

Another evidence provided for the non inferiority of short term treatment of bacterial skin and  skin structure infections with a new drug is seen in ‘ Moran and colleagues’ trial. 

Tedizolid Dosing forms & strength: tablet 200mg. Lyophilized powder for reconstitution 200mg/vial. 

Indication: for acute bacterial Skin and skin structure infections. 

Mechanism of action: Tedizolid phosphate is the prodrug of tedizolid.  It performs  it’s action by binding to the 50S subunit of bacterial ribosome, and inhibits protein synthesis. 

Reference: The Lancet Infectious Diseases, Volume 14, issue 8.


Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s